CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award SVP and Chief Development Off. acquired 5,000 shares (grant or award)
- 4 Open-market sale Director sold 20,000 shares at $4.54 ($90,800)
- 4 Grant or award Chairman and CEO acquired 75,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 7,750 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Open-market sale Director sold 12,000 shares at $4.99 ($59,880)
- 4 Grant or award VP and Corporate Compliance acquired 5,500 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 6,000 shares (grant or award)
Page 21 of 26 · 512 filings